Cardiovascular risk factor management in patients with diabetes: Does management differ with disease duration?

• Published in: Journal of diabetes and its complications 2021-10, Vol.35 (10), p.107997-107997, Article 107997
• Main Authors: Lo, Samantha, Leiter, Lawrence A., Langer, Anatoly, Tan, Mary, Goldin, Lianne, Harris, Stewart, Yale, Jean-Francois, Ekoe, Jean-Marie, Lin, Peter J., Goodman, Shaun G., Yan, Andrew T.
• Format: Article
• Language: English
• Subjects: Antihypertensive Agents - therapeutic use; Antihypertensives; Blood Glucose; Blood pressure; Cardiovascular disease; Cardiovascular Diseases - complications; Cardiovascular Diseases - epidemiology; Cardiovascular Diseases - prevention & control; Cholesterol, LDL - blood; Coronary vessels; Data collection; Diabetes; Diabetes Mellitus, Type 2 - complications; Diabetes Mellitus, Type 2 - drug therapy; Diabetes Mellitus, Type 2 - epidemiology; Glucose; Glycated Hemoglobin A - analysis; Glycemic Control; Heart Disease Risk Factors; Hemoglobin; Humans; Hypertension; Lipids; Mortality; Patients; Primary care; Risk factors; Statistical analysis; Time Factors; Type 2 diabetes mellitus
• ISSN: 1056-8727; 1873-460X
• DOI: 10.1016/j.jdiacomp.2021.107997

Our objective was to examine risk factor modification targets and treatment in relation to duration of diabetes. The Diabetes Mellitus Status in Canada (DM-SCAN) study collected data on 5109 patients with type 2 diabetes mellitus (T2DM) in 2012 in primary care. We compared the prevalence of vascular complications, treatment targets, and interventions between patients with diagnosed diabetes duration ≤10 and > 10 years. Physicians more frequently assigned HbA1c (glycated hemoglobin) targets of 7.1–8.5% (54–69 mmol/mol) to patients with longer duration of diabetes (n = 1647) (19.8% vs 9.5%, p